- VernacularTitle: 肺炎前置病房在应对新型冠状病毒肺炎疫情暴发中的探索与实践
- Author:
Bing FENG
1
;
Ting WANG
1
;
Hai-jing FU
1
;
Si-qi HAN
1
;
Qun-yan ZHANG
1
;
Li-wen HU
1
;
Ji-hong ZHONG
1
;
Qin WANG
1
;
Xiao-yuan CHU
1
Author Information
- Publication Type:Journal Article
- Keywords: coronavirus disease 2019 (COVID-19); pneumonia pre-ward; emerging respiratory infectious disease
- From: Journal of Medical Postgraduates 2020;33(8):858-860
- CountryChina
- Language:Chinese
- Abstract: Corona virus disease 2019 (COVID-19) is an emerging respiratory infectious disease first reported in Wuhan, China, with subsequent spread worldwide. Except for a professional medical team sending to the affected area, fever clinics, fever wards, as well as expert groups were set up by Jinling hospital at the first time. Meanwhile, a pneumonia pre-ward was established according to the needs of epidemic prevention and control. To date, a total of 22 pneumonia patients negative for COVID-19 nucleic acid test have been treated in this pneumonia pre-ward, of which 6 are still under treatment, 16 are cured and discharged, with the medical staff free from infection. This article discusses the application and value of pneumonia pre-ward in COVID-19 from aspects of ward setting and management, work flow, treated cases, experience in diagnosis and treatment, etc.